As we approach Mid-July, global listed animal health and veterinary diagnostics companies are lining up announcements of dates of quarterly results and earnings call / investors’ calls for Q2′ 2026 revenues.
Although almost all the listed animal health companies shared forecast and colour for the next couple of quarters – Zoetis earnings and commentary is the most watched out for, on account of a threat of Class Action Suit, following its Q1′ 2026 earnings announcement.
The upcoming financial calendar for the top pure-play listed animal health companies is as under:
Company (Ticker) |
Core Focus |
Upcoming Event Date |
Details |
Virbac (VIRP) |
Companion & Farm Animal Pharmaceuticals |
July 20, 2026 |
Q2 2026 Second Quarter Sales (After Market Close) |
IDEXX Laboratories (IDXX) |
Veterinary Diagnostics & Software |
August 4, 2026 |
Q2 2026 Earnings Call (8:30 AM EDT) |
Elanco Animal Health (ELAN) |
Parasiticides & Livestock Therapeutics |
August 5, 2026 |
Q2 2026 Earnings Announcement & Call |
Zoetis (ZTS) |
Global Market Leader (Therapeutics/Vaccines) |
August 6, 2026 |
Historically reports Q2 numbers within the first week of August. |
Phibro Animal Health (PAHC) |
Livestock Nutrition & Vaccines |
September 2, 2026 |
Q4/Full-Year Fiscal 2026 Earnings (Fiscal year ends June 30) |
Key Trends to Watch This Earnings Season
-
Inventory & Veterinary Clinic Traffic: Analysts are highly focused on companion animal clinical volume and whether post-pandemic companion animal care spending continues to stabilize.
-
Innovation & Launches: For companies like Zoetis and Elanco, updates on pipeline milestones—specifically next-generation parasiticides and monoclonal antibodies for canine/feline chronic pain—remain primary stock drivers.
-
Livestock Margins: Producers like Phibro and Virbac will give key insights into industrial farm economics (poultry, swine, and cattle) amid fluctuating grain input costs
